Carboxy Therapy Market Size & Share | Global Report 2028

The carboxy therapy market is valued US$ 85.24 million in 2021; it is estimated to grow at a CAGR of 12.4% from 2022 to 2028.

Carboxy therapy employs injecting carbon dioxide into the treatment area to stimulate blood flow. It is a nonsurgical treatment and is widely used to treat cellulite, stretch marks, and dark under-eye circles.

The carboxy therapy market is segmented into type, application, end user, and geography. By geography, the carboxy therapy market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market with an emphasis on parameters such as market trends and dynamics and the competitive analysis of the globally leading market players.  

Strategic Insights

Lucrative Regions for Carboxy Therapy Market

Get more information on this report : Request Free Sample PDF

Market Insights

Growing Adoption of Noninvasive Aesthetic Procedures Boosts Carboxy Therapy Market

The World Health Organization (WHO) recognizes waste reduction in healthcare delivery as an essential aspect of strengthening healthcare systems. Technological advancements have led to the development of surgical approaches that minimize waste and achieve better results with available resources. Minimally invasive surgeries (MIS) and noninvasive procedures are among the approaches that result in low waste generation and reduced medical expenses. Further, these procedures ensure low absenteeism at the workplace, which has a net positive effect on the productivity of an economy. According to the International Society of Aesthetic Plastic Surgery (ISAPS), ~14,400,347 million minimally invasive cosmetic procedures were performed globally in 2020. The implementation of these procedures grew by 22.7% from 2016 to 2020 globally.

Minimally invasive procedures result in faster recovery, lesser scarring, reduced stress, and better patient satisfaction. The modern concept of natural and harmonious rejuvenation is based on a comprehensive, three-dimensional, multi-layered approach that combines several active ingredients and techniques in procedures, such as skin relaxation, surface renewal, and skin tightening, depending on the specific patient’s needs. Since the appearance of the skin is considered an essential factor in wellbeing and health, the number of aesthetic procedures performed worldwide is increasing steadily.

Further, nonsurgical procedures include facial injections, which help correct facial lines and wrinkles and provide a reduction of cellulite and unwanted fat with minimal side effects. The ISAPS defines a nonsurgical cosmetic procedure as an effective and safe procedure for people opting for subtle enhancement and surgical result enhancement that requires less recovery time. These procedures often do not require extensive training, unlike surgical procedures that are associated with more risks.

As per ISAPS estimations, the number of nonsurgical cosmetic procedures increased by 44% in 2021 compared to 2020. In the past 20 years, minimally invasive procedures have undergone continuous innovations. In 2020, doctors performed 13.2 million minimally invasive procedures in the US. Thus, the surge in the uptake of minimally invasive and noninvasive aesthetic procedures is driving the carboxy therapy market.

The modern concept of natural and harmonious rejuvenation is based on a comprehensive, three-dimensional, multi-layered approach that combines several active ingredients and techniques in procedures such as skin relaxation, surface renewal, and skin tightening, depending on the specific patient’s needs. Since the appearance of the skin is considered an important factor in wellbeing and health, the number of aesthetic procedures performed worldwide is increasing steadily. Further, nonsurgical procedures include facial injections which help in the correction of facial lines, wrinkles, cellulite reduction, and unwanted fat reduction with minimal side effects. The International Society of Aesthetic Plastic Surgery (ISAPS) defines a nonsurgical cosmetic procedure as an effective and safe procedure for those who are willing to undergo subtle enhancement and surgical result enhancement with lower recovery periods; these procedures often do not require extensive training, unlike surgical procedures that are associated with greater risks. As per ISAPS estimations, the number of nonsurgical cosmetic procedures increased by 44% in 2021 compared to 2020. In the past 20 years, minimally invasive procedures have undergone continuous innovations. In 2020, doctors performed 13.2 million minimally invasive procedures in the US. Thus, the surge in the adoption of minimally invasive and noninvasive aesthetic procedures is driving the carboxy therapy market growth.

Type Insights

Based on the type, the carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment held the largest market share in 2021. However, the portable segment is anticipated to register the highest CAGR of 12.6% during the forecast period. The demand for tabletop carboxy therapy machine is rising as it is widely used for pain management and medical aesthetics.

Carboxy Therapy Market, by Type – 2021 and 2028

Get more information on this report : Request Free Sample PDF

Based on application, the carboxy therapy market is segmented into aesthetic medicine, dermatology, gynecology, angiology, orthopedics and rheumatology, sports medicine, and others. The aesthetic medicine is subsegmented into cellulite, stretch marks, alopecia, and dark under-eye circles. In 2021, the aesthetic medicine segment held the largest share of the market. However, the dermatology segment is expected to grow at a significant CAGR of 12.9% during the forecast period. Increasing demand for various noninvasive or minimally invasive services such as laser resurfacing, aesthetic injectables, and other services is increasing with increased consumer interest in skin texture and tone improvement are driving the growth of the aesthetic medicine segment during the forecast period.

End User Insights

Based on the end user, the carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness center. The hospitals segment held the largest market share in 2021. However, the aesthetic clinics segment is expected to register the highest CAGR of 12.7% during the forecast period. The growth of the hospital segment is attributed to the increase in the number of carboxy therapy and the surge in demand for aesthetic medicine and dermatological procedures.

Organic developments such as product launches and approvals are highly adopted strategies by companies in the carboxy therapy market. A few of the recent key market developments are listed below:

• In March 2021, Air Liquide signed an agreement with the Gippsland Basin Joint Venture, a 50-50 joint venture between BHP Petroleum (Bass Strait) Pty Ltd and Esso Australia Resources Pty Ltd, for the construction of a new facility to distribute carbon dioxide to Australian industries. This facility will be built next to the Longford Gas Conditioning Plant, owned by Gippsland Basin Joint Venture and operated by Esso Australia, which will capture CO2 from its operations and deliver it to Air Liquide for purification and reuse.
• In March 2019, Air Products acquired ACP Europe SA, one of the largest independent carbon dioxide producing companies in Europe. The acquisition will help the company serve its customers efficiently and boost growth opportunities across additional European countries.
• In January 2020, Cosmo Pro Ltd. launched DIOX carboxytherapy system. The DIOX system features a touch-screen interface and both automatic and manual modes.

Company Profiles

• DTA Medical
• Cosmo Pro Ltd.
• Carbossiterapia Italiana
• Beijing Jontelaser Technologies Co., Ltd.
• Kastner-Praxisbedarf
• Mezopharma
• MBE Medical Division
• Nick Fanavaran Plasma Company